|
|
Volumn 74, Issue , 1997, Pages 469-486
|
|
Clinical aspects of ribozymes as therapeutics in gene therapy.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
RIBOZYME;
CLINICAL PROTOCOL;
CLINICAL TRIAL;
GENE THERAPY;
GENETIC DISORDER;
GENETICS;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
INFORMED CONSENT;
LEGAL ASPECT;
METHODOLOGY;
NEOPLASM;
PATIENT SELECTION;
REVIEW;
SAFETY;
UNITED STATES;
VIRUS INFECTION;
ANTINEOPLASTIC AGENTS;
CLINICAL PROTOCOLS;
CLINICAL TRIALS;
GENE THERAPY;
GENETIC DISEASES, INBORN;
HIV INFECTIONS;
HUMANS;
INFORMED CONSENT;
NEOPLASMS;
PATIENT SELECTION;
RNA, CATALYTIC;
SAFETY;
UNITED STATES;
VIRUS DISEASES;
MLCS;
MLOWN;
|
|
EID: 0030630401
PISSN: 10643745
EISSN: None
Source Type: Journal
DOI: 10.1385/0-89603-389-9:469 Document Type: Review |
|
Times cited : (6)
|
|
References (71)
|
